Marketing-authorisation holder · Argentina
Astrazeneca S.A.
2 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Argentina
2 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BELOZOK23,75 mg | 47,5 mg | 95 mg · Comprimido de liberación prolongada | Metoprolol | Argentina | unknown | |
| PLENDIL10 mg | 5 mg · Comprimido de liberación prolongada | Felodipine | Argentina | unknown |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Argentina | 2 | 0 | 2 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Ministerio de Salud / ANMAT, historical VNM changes, Actualizaciones del Vademecun Nacional de Medicamentos (VNM) - julio 2018, https://datos.salud.gob.ar/dataset/vademecun-nacional-de-medicamentos-vnm, CC BY 4.0, acquired 2026-10-09; structured factual adaptation.
Licence: Creative Commons Attribution
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.